Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Biosimilars Cardiorenalmetabolic Dermatology Gastroenterology Hematology Hepatology Immunology Infectious Disease Mental Health Neurology Obesity Oncology Ophthalmology Pulmonology Rare Disease Respiratory Rheumatology Women's Health

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars Center on Health Equity & Access Digital Health Formulary Gene Therapy Guidelines Health Care Administration Health Care Cost Health Care Delivery Insurance Policy Population Health Product Approvals and Launches Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Oncology

Latest News

Depressed woman | Image Credit: panitan - stock.adobe.com

Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors

By Brooke McCormick

January 31st 2026

These findings suggest the mental health burden in nonmelanoma skin cancer reflects broader social and clinical factors rather than disease-specific effects.

Young man holding blue ribbon | Image Credit: Jo Panuwat D - stock.adobe.com

CRC Becomes Leading Cause of Cancer-Related Death in Younger Adults, Highlighting Prevention Gaps

By Brooke McCormick

January 26th 2026

Doctor conducting liquid biopsy | Image Credit: syhin_stas - stock.adobe.com

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

By Brooke McCormick

January 25th 2026

Psychiatric disorders | Image Credit: Olivier Le Moal - stock.adobe.com

Psychiatric Disorders Linked to Higher CRC Risk but Not Mortality

By Brooke McCormick

January 21st 2026

Miami | Image Credit: ©SeanPavonePhoto-stock.adobe.com

Precision, Access, and the Patient Journey: Navigating the Complexities of Modern Oncology

By Laura Joszt, MA

January 20th 2026

Latest CME Events & Activities

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

View More

Payment for Pharmacist Services: 2025 Update

1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law

View More

More News

Unnecessary High-tech Prostate Cancer Treatments Overprescribed

Many men are still receiving potentially unnecessary and costly treatments, even after being diagnosed as having prostate cancer with a low risk of dying.

Read More

Men with Low-Risk Prostate Cancer Receiving Unnecessary, Expensive Treatment

Read More

Cervical Cancer Screening Overuse and Underuse: Patient and Physician Factors

Cristina M. Almeida, MD, MPH;Michael A. Rodriguez, MD, MPH;Samuel Skootsky, MD;Janet Pregler, MD;Neil Steers, PhD;Neil S. Wenger, MD, MPH

Cervical cancer screening underuse and overuse occur commonly in clinical practice and identifiable patient and physician factors can be targeted for quality improvement.

Read More

NCCN Guidelines Update: NCCN 18th Annual Conference, Advancing the Standards of Cancer Care

Read More

Sledge Expects 'Big Data' to Generate Big Changes

Anita T. Shaffer

Read More

Use of Personalized Medicine to Select Adjuvant Breast Cancer Therapy

Anna Azvolinsky, PhD

Read More

The Changing Landscape of Oncology: Impact for Payers and Providers

Dawn Holcombe, MBA

Read More

Aspirin May Slow DNA Mutations, Fight Cancer

Read More

Episode 14 - Conclusion: Final Thoughts Concerning Immunotherapy

Episode 14 - Conclusion: Final Thoughts Concerning Immunotherapy

Watch

Episode 13 - Healthcare Reform's Impact on Immunotherapy (Part 2)

Episode 13 - Healthcare Reform's Impact on Immunotherapy (Part 2)

Watch

Epsiode 12 - Healthcare Reform's Impact on Immunotherapy (Part 1)

Epsiode 12 - Healthcare Reform's Impact on Immunotherapy (Part 1)

Watch

Epsiode 11 - The Impact of Combination Therapies on Resource Allocations

Epsiode 11 - The Impact of Combination Therapies on Resource Allocations

Watch

Episode 10 - Measuring Economic Burden or Value Against Clinical Outcomes

Episode 10 - Measuring Economic Burden or Value Against Clinical Outcomes

Watch

Episode 9 - The Payer Approach to Immunotherapy

Episode 9 - The Payer Approach to Immunotherapy

Watch

Episode 8 - A Managed Care Approach to Immunotherapy

Episode 8 - A Managed Care Approach to Immunotherapy

Watch

Episode 7 - Immunotherapy: Where Is It At? Where Is It Headed?

Episode 7 - Immunotherapy: Where Is It At? Where Is It Headed?

Watch

Episode 6 - Recommended Guidelines and Payer Challenges

Episode 6 - Recommended Guidelines and Payer Challenges

Watch

Episode 5 - Recent Additions to the Pipeline

Episode 5 - Recent Additions to the Pipeline

Watch

Episode 4 - Pushing Reform through Immunotherapy

Episode 4 - Pushing Reform through Immunotherapy

Watch

Episode 3 - Managed Care Concerns and Treatment Accessibility

Episode 3 - Managed Care Concerns and Treatment Accessibility

Watch

Episode 1 - The Advent of Cancer Immunotherapy: Addressing Unmet Needs

Episode 1 - The Advent of Cancer Immunotherapy: Addressing Unmet Needs

Watch

Episode 2 - Diverse Applications Amidst a Growing Pipeline

Episode 2 - Diverse Applications Amidst a Growing Pipeline

Watch

Tailor Treatment Plans to Improve Outcomes in Managing NSCLC

Read More

Looking at Specialty Pharmaceutical Rejections

Dea Belazi, PharmD, MPH

Read More

Third-Party Validation of Observed Savings From an Oncology Pathways Program

Bruce A. Feinberg, DO;Scott Milligan, PhD;Joseph Cooper, BS;Winston Wong, PharmD;Daniel Winn, MD;Neil Schneider, ASA, MAAA;Sheamus Parkes, FSA, MAAA;Jeffrey Scott, MD

Read More

I-SPY Trials Seek Effective New Drug Combinations Using Adaptive Trial Design

Read More

Observation of Prostate Cancer Both Effective and Cost-Efficient

Read More

Tailored Cancer Treatment Plans May Be Latest Trend

Read More

Proton Therapy Treatment Centers in Risk-sharing Health Systems

Hospital systems across the country are increasingly vying to establish some of the first treatment centers to provide proton beam therapy, a high-tech radiation treatment for cancer.

Read More

Supreme Court Rules: No Patents for Human Genes

Read More

...

177 178 179 180 181 182 183 184 185

...

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2026 MJH Life Sciences
AJMC®
All rights reserved.